Log in to save to my catalogue

Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular car...

Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular car...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_983096be3b1246c68b4d1ba13cd275bb

Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy

About this item

Full title

Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy

Publisher

United States: John Wiley & Sons, Inc

Journal title

Cancer Reports, 2022-11, Vol.5 (11), p.e1613-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
Therapeutic strategies for unresectable hepatocellular carcinoma (u‐HCC) in geriatric patients are important for real‐world practice. However, there remain no established biomarkers or therapeutic strategies regarding the best second‐line agent after atezolizumab plus bevacizumab therapy.
Aim
In this study, we investigated the u...

Alternative Titles

Full title

Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_983096be3b1246c68b4d1ba13cd275bb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_983096be3b1246c68b4d1ba13cd275bb

Other Identifiers

ISSN

2573-8348

E-ISSN

2573-8348

DOI

10.1002/cnr2.1613

How to access this item